We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+14.01%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$8.18B
AUM Growth
+$2.34B
Cap. Flow
+$1.61B
Cap. Flow %
19.64%
Top 10 Hldgs %
19.29%
Holding
1,524
New
270
Increased
735
Reduced
398
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 15.43%
2 Energy 8.23%
3 Communication Services 7.74%
4 Consumer Discretionary 7.26%
5 Financials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOV icon
1476
NOV
NOV
$7.45B
-18,201
Closed -$277K
NRIX icon
1477
Nurix Therapeutics
NRIX
$2.44B
-9,145
Closed -$109K
NUVB icon
1478
Nuvation Bio
NUVB
$2.31B
-60,951
Closed -$107K
NUVL
1479
DELISTED
Nuvalent
NUVL
-1,654
Closed -$117K
OPK icon
1480
Opko Health
OPK
$929M
-338,948
Closed -$563K
PGEN icon
1481
Precigen
PGEN
$1.95B
-71,566
Closed -$107K
RAPT
1482
DELISTED
RAPT Therapeutics
RAPT
-14,217
Closed -$139K
RCMT icon
1483
RCM Technologies
RCMT
$197M
-16,566
Closed -$258K
RCUS icon
1484
Arcus Biosciences
RCUS
$3.54B
-13,922
Closed -$109K
REPL icon
1485
Replimune Group
REPL
$724M
-10,814
Closed -$105K
RIG icon
1486
Transocean
RIG
$5.88B
-221,615
Closed -$703K
RLAY icon
1487
Relay Therapeutics
RLAY
$4.1B
-36,293
Closed -$95.1K
RVMD icon
1488
Revolution Medicines
RVMD
$39.9B
-3,255
Closed -$115K
RXRX icon
1489
Recursion Pharmaceuticals
RXRX
$1.62B
-18,624
Closed -$98.5K
RYTM icon
1490
Rhythm Pharmaceuticals
RYTM
$7.51B
-11,912
Closed -$631K
SDGR icon
1491
Schrodinger
SDGR
$1.14B
-5,368
Closed -$106K
SDRL icon
1492
Seadrill
SDRL
$2.7B
-15,615
Closed -$390K
SEE
1493
DELISTED
Sealed Air
SEE
-3,464
Closed -$100K
SGOL icon
1494
abrdn Physical Gold Shares ETF
SGOL
$6.95B
-5,728
Closed -$171K
SIG icon
1495
Signet Jewelers
SIG
$3.75B
-4,301
Closed -$250K
SMHI icon
1496
SEACOR Marine Holdings
SMHI
$216M
-17,233
Closed -$87.2K
SMMT icon
1497
Summit Therapeutics
SMMT
$10.8B
-6,328
Closed -$122K
SNDX icon
1498
Syndax Pharmaceuticals
SNDX
$1.85B
-9,769
Closed -$120K
STNG icon
1499
Scorpio Tankers
STNG
$3.89B
-6,216
Closed -$234K
STRO icon
1500
Sutro Biopharma
STRO
$403M
-13,662
Closed -$88.9K

Similar funds

Exchange Traded Concepts's Q2 2025 Portfolio in Review

As of Q2 2025, Exchange Traded Concepts held 1,524 positions worth $8.18B, up 40% from $5.84B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Exchange Traded Concepts deployed $1.61B of net new capital in Q2 2025, opening 270 new positions and adding to 735 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 2,404,388 shares worth $175M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $61.8M trimmed.

  • Exchange Traded Concepts's largest Q2 2025 buy was State Street SPDR Portfolio S&P 500 ETF: 2,404,388 shares worth $175M.
  • Exchange Traded Concepts added most to Apple in Q2 2025, an estimated $49M increase.
  • Exchange Traded Concepts's biggest Q2 2025 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $61.8M.
  • Exchange Traded Concepts fully exited Vanguard Ultra-Short Bond ETF in Q2 2025, selling an estimated $82.5M.
  • Exchange Traded Concepts's ten largest holdings make up 19% of its $8.18B portfolio in Q2 2025.
  • Exchange Traded Concepts opened 270 new positions and closed 118 in Q2 2025.
  • Exchange Traded Concepts's portfolio value rose 40% quarter-over-quarter to $8.18B.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.